Edgen Stock·Sep 19 2025, 09:26戻る
戻る
Johnson & Johnson Price Target Raised by Wolfe Research Amid Talc Litigation Confidence
Edgen Stock·Sep 19 2025, 09:26
[1] Wolfe Research Lifts PT for Johnson & Johnson (JNJ), Keeps Outperform Rating (https://finance.yahoo.com/news/wolfe-research ...)[2] Johnson & Johnson stock price target raised to $195 from $175 at Wolfe Research (https://vertexaisearch.cloud.google.com/groun ...)[3] Johnson & Johnson's icotrokinra outperforms deucravacitinib in psoriasis trials (https://vertexaisearch.cloud.google.com/groun ...)